TRANSCRANIAL PULSE STIMULATION (TPS) OPENS UP NEW HORIZONS IN THE TREATMENT OF PSYCHIATRIC PATIENTS

The evidence base for Transcranial Pulse Stimulation (TPS) continues to grow, with recent studies demonstrating its versatility and safety across a broad spectrum of neurological and psychiatric conditions. From systemic meta-analyses to novel off-label applications, TPS is proving to be a transformative tool in neuromodulation. Key Research Summaries: Broad Clinical Efficacy: A systematic review and meta-analysis of 15 clinical studies (518 patients) confirms that TPS produces predominantly positive effects on cognitive, motor, and emotional functions in conditions ranging from Alzheimer’s to ADHD, maintaining a strong safety profile throughout., Neurodevelopmental Breakthroughs: Post-hoc analysis of a randomized controlled trial indicates that TPS induces changes in large-scale neural networks in adolescents with Autism Spectrum Disorder (ASD) , leading to marked improvements in behavioral flexibility and social communication., Advanced Parkinsonism (MSA-P): A recent case report highlights the successful use of TPS in managing Multiple System Atrophy (Parkinsonian type). Following six sessions, a 73-year-old patient showed significant reductions in rigidity and bradykinesia., Chronic Pain Management: In a novel application for Refractory Primary Knee Osteoarthritis (KOA) , prospective data shows that TPS sessions resulted in a significant reduction in pain intensity without serious side effects, suggesting a new path for neuromodulation in orthopedics., The Road Ahead: With multiple publications currently in preparation for the remainder of 2026, the clinical community anticipates even deeper insights into the long-term neuroplastic effects of TPS and its role in personalized medicine.